Eli Lilly has opened up a second market for its new Alzheimer's disease therapy Kisunla, after Japan followed the US in approving the drug. Kisunla (donanemab) is the second in a new generation of ...

Pharmacists will be able to substitute Eli Lilly’s insulin Lispro for Sanofi’s Humalog. Concerns over Verzenio in Japan However there were worries for Lilly in Japan, after it was reported ...

Eli Lilly plans to release its diabetes and weight-loss drug, Mounjaro, in major global markets like China, India, Brazil, ...

A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...